CVS HEALTH CORP (CVS) Stock Institutional Trading Activity


CVS HEALTH CORP (CVS) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Hancock Classic Value, Ariel Appreciation Fund, Olstein Capital Management, Cullen Value Fund, and Tweedy, Browne Co All Funds (US). Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2019Parnassus Endeavor FundSell-2,152,83111,639,429$627,715
Q1 2019Sequoia Financial AdvisorsSell-54,1797,681$414
Q1 2019Matrix Advisors Value FundBuy57,290208,688$11,255
Q1 2019Renaissance Technologies LLCSell-1,019,821303,553$16,371
Q1 2019Vulcan Value PartnersBuy2,881,9537,958,469$429,200
Q1 2019Hancock Classic ValueBuy502718,884$38,769
Q4 2018Olstein Capital ManagementSell-1,000127,000$8,321
Q4 2018Dodge & Cox Stock FundBuy923,20316,048,889$1,051,523
Q4 2018Parnassus Endeavor FundSell-2,675,10113,792,260$903,669
Q4 2018Sequoia Financial AdvisorsBuy56,43761,860$4,053
Q4 2018Matrix Advisors Value FundSell-690151,398$9,920
Q4 2018Renaissance Technologies LLCSell-596,1311,323,374$86,707
Q4 2018Vulcan Value PartnersSell-734,5635,076,516$332,613
Q4 2018Eagle Capital ManagementBuy38,54638,546$2,526
Q4 2018Hancock Classic ValueSell-698718,382$47,068
Q3 2018Olstein Capital ManagementSell-36,000128,000$10,076
Q3 2018Dodge & Cox Stock FundBuy15,123,05615,125,686$1,190,694
Q3 2018Parnassus Endeavor FundSell-192,14016,467,361$1,296,311
Q3 2018Sequoia Financial AdvisorsSell-1095,423$427
Q3 2018Matrix Advisors Value FundSell-8,938152,088$11,972
Q3 2018Vulcan Value PartnersSell-3,711,6655,811,079$457,448
Q3 2018Hancock Classic ValueSell-3,706719,080$56,606
Q2 2018Olstein Capital ManagementSell-21,000164,000$10,553
Q2 2018Parnassus Endeavor FundBuy350,87216,659,501$1,072,039
Q2 2018Sequoia Financial AdvisorsSell-1,3965,532$356
Q2 2018Matrix Advisors Value FundBuy8,681161,026$10,362
Q2 2018Vulcan Value PartnersBuy217,4069,522,744$612,789
Q2 2018Hancock Classic ValueBuy19,145722,786$46,511
Q1 2018Olstein Capital ManagementBuy48,500185,000$11,509
Q1 2018Parnassus Endeavor FundBuy9,095,49916,308,629$1,014,560

Frequently asked questions about CVS activity

  • Which institutional owners are buying CVS?

    Institutional owners buying CVS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in CVS activity?

    "Buy" means an investor increased their reported position in CVS compared to the prior reporting period. This reflects growing exposure to CVS HEALTH CORP (CVS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in CVS increasing?

    Institutional interest in CVS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.